530125 — Samrat Pharmachem Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Samrat Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2022 March 31st	R2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	—	12 M	12 M	12 M
Source:	ARS	PRESS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Preliminary	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	147	119	97.4	5.24	63.7
Net Total Accounts Receivable
Net Total Receivables	436	517	693	565	510
Total Inventory
Total Other Current Assets
Total Current Assets	713	991	1,026	1,034	1,038
Net Property, Plant And Equipment	99.8	107	107	105	128
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	846	1,166	1,217	1,215	1,244
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	373	532	564	496	558
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	378	534	567	497	562
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	468	631	650	718	682
Total Liabilities & Shareholders' Equity	846	1,166	1,217	1,215	1,244
Total Common Shares Outstanding